the absolute bioavailability and dose proportionality of betaxolol [ ( +/- ) -1- ( p- [ 2-cyclopropylmethoxy ) ethyl ] phenoxy ] -3- ( isopropylamino ) -2-propanol hydrochloride ] , a cardioselective beta-adrenergic antagonist effective in the treatment of angina and hypertension , was studied in 12 healthy male subjects using a four-way crossover latin square design .
C0005320
betaxolol
C0020538
hypertension